Navigation Links
New Jersey Targets Life-Sciences Investors at World's Largest Biotechnology Event
Date:6/21/2011

PRINCETON, N.J., June 21, 2011 /PRNewswire/ -- On June 28, Lieutenant Governor Kim Guadagno, Tracye McDaniel, president and CEO of Choose New Jersey (the state's independently funded and operated nonprofit economic development organization) and Dr. Jay Tischfield, CEO, Rutgers University Cell & DNA Repository (RUCDR) are traveling to Washington, DC, to meet with investors and tout New Jersey's life-sciences industries at the world's largest biotechnology event, the 2011 BIO International Convention.

At the BIO Convention, the delegation will showcase financial incentive programs that assist both major corporations and emerging healthcare companies which have a proven track record in investment attraction and job creation. Bayer HealthCare's announcement in April to consolidate its East Coast business in New Jersey and the opening of Watson Pharmaceuticals' new global headquarters in Parsippany this month can be credited, in part, to the state's business-friendly policies. These projects will directly impact 2,000 jobs in the state.

"New Jersey offers unparalleled opportunities for pharmaceutical, biotechnology and medical device businesses. Raising awareness of these assets – like access to capital and to one of the best-educated and highly-skilled workforces in the country – is instrumental in our efforts to attract and retain companies in the state," said Tracye McDaniel, president and CEO of Choose New Jersey. "The considerable concentration of life-science businesses in New Jersey and recent investments from major corporations are a testament to what the region has to offer."

In addition, world-renowned geneticist Dr. Jay Tischfield will be on hand to highlight groundbreaking mental health research at RUCDR. The globally-recognized repository serves almost 300 clients including nearly every major medical and research school in the country, leading organizations such as the National Institute for Mental Health and Autism Speaks, and major corporations. As a professor of genetics at Rutgers University, Dr. Tischfield will also provide insight on New Jersey's highly-educated workforce, which consistently ranks among the nation's top for degreed professionals within science and engineering.  

Along with attending the conference, Choose New Jersey will host a C-level executive event to provide networking opportunities to further promote the state's biotechnology and pharmaceutical industries.

Choose New Jersey:

Choose New Jersey is an independently-funded and operated nonprofit corporation created to promote New Jersey as a place to invest and do business. For more information visit: www.chooseNJ.com.


'/>"/>
SOURCE Choose New Jersey
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
2. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
3. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
4. NeoStem Expands Stem Cell Collection Center Network Into New Jersey Led by Leading Plastic Surgeon and Anti-Aging Authority
5. ChemOutsourcing Unveils 2009 Attendee List for September Show in New Jersey
6. New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems
7. New Jerseys Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development
8. Lunch and Learn Workshop for New Jersey-based FDA-Regulated Companies
9. Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
10. SOCMA President to Lead ChemOutsourcing Keynote Panel on API Supply Base on Wednesday, September 15 at New Jersey Show
11. Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... (PRWEB) , ... June 23, ... ... the launch of a redesigned, easier-to-navigate website for all six of their ... for physicians, nurses, dentists, pharmacists, physical and occupational therapists, and biotechnicians, DocCafe.com ...
(Date:6/22/2017)... ... June 22, 2017 , ... AESKU.GROUP, an ... Diagnostische Systeme & Technologien GmbH, thereby expanding its product portfolio to include allergy ... fever, urticaria, asthma, atopic eczema or a food allergy. Allergies are escalating to ...
(Date:6/22/2017)... MD (PRWEB) , ... June 22, 2017 , ... ... solutions provider, announced the release of Limfinity® version 6.5, a content-packed update to ... framework continue to gain a larger and more diverse base of customers among ...
(Date:6/20/2017)... 20, 2017  Kibow Biotech Inc., a pioneer in ... issuance of a new patent covering a unique method ... U.S. Patent and Trademark Office on May 23 rd ... Buzz of Bio award in 2014 in ... non-drug approaches to chronic disease. Renadylâ„¢, the first and ...
Breaking Biology Technology:
(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):